Physician profile
Jeffrey C Thomas
NPI 1306118328
$4,268.40
in general payments reported to CMS, 2019-2025
35 companies · $381 in 2025
The $381 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $530 · 2020: $1,707 · 2021: $408 · 2022: $572 · 2023: $334 · 2024: $336 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,051.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,360.81 | 2019-2022 | |
| Stryker Corporation | $489.73 | 2020-2023 | 7 X 23mm Citrelock Implant, Ortholoc 2 Lapifuse |
| Nevro Corp. | $282.77 | 2022-2024 | Senza |
| Djo, LLC | $251.30 | 2019-2023 | Cmf |
| Smith+Nephew, INC. | $244.39 | 2019-2025 | Grafix Pl |
| Integra Lifesciences Corporation | $150.12 | 2020-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Surgenex LLC | $149.93 | 2025 | Ardeograft, Surmatrix, Pellograft |
| Zyla Life Sciences, INC. | $125.59 | 2019-2020 | |
| Amgen INC. | $116.48 | 2024-2025 | Krystexxa |
| Horizon Therapeutics Plc | $112.50 | 2019-2021 | |
| Depuy Synthes Sales INC. | $93.28 | 2019 | |
| Melinta Therapeutics, LLC | $91.70 | 2020-2025 | Orbactiv, Kimyrsa |
| Wright Medical Technology, INC. | $65.23 | 2019-2020 | |
| Orthofix Medical, INC. | $63.51 | 2022-2025 | Physio-Stim |
| Abbvie INC. | $58.27 | 2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $56.40 | 2024 | Venacure 1470 Pro |
| Organogenesis INC. | $55.31 | 2020 | |
| Zimmer Biomet Holdings, INC. | $52.25 | 2022 | |
| Biowound Solutions, INC. | $51.35 | 2024 | Bio-Connekt |
| Acell, INC. | $50.40 | 2019-2020 | |
| Forthright Medical - Az, LLC | $40.59 | 2024 | |
| Treace Medical Concepts, INC. | $39.63 | 2022 | |
| Flower Orthopedics Coporation | $36.36 | 2024 | |
| Aap Implants INC | $34.98 | 2022 | |
| Advanced Oxygen Therapy INC. | $25.22 | 2023-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Medtronic Vascular, INC. | $24.57 | 2019 | |
| Reprise Biomedical, INC. | $23.05 | 2025 | Miro3d |
| Nalu Medical, INC. | $20.64 | 2024 | Nalu Neurostimulation System |
| Celularity INC. | $20.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.22 | 2023 | Seglentis |
| Merck Sharp & Dohme LLC | $14.95 | 2019 | |
| Osiris Therapeutics INC. | $13.97 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.54 | 2025 | Jublia |
| Biotissue Holdings INC. | $12.71 | 2021 | |
| Bioventus LLC | $11.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.